T2 Biosystems, Inc.
TTOO · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$50,077 | -$62,003 | -$49,241 | -$46,798 |
| Dep. & Amort. | $859 | $2,271 | $2,538 | $3,156 |
| Deferred Tax | $0 | $0 | -$1,024 | -$258 |
| Stock-Based Comp. | $4,351 | $6,493 | $7,090 | $3,913 |
| Change in WC | -$4,042 | -$503 | -$2,171 | -$6,538 |
| Other Non-Cash | $773 | $3,113 | $3,934 | $3,310 |
| Operating Cash Flow | -$48,136 | -$50,629 | -$38,874 | -$43,215 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$192 | -$339 | -$460 | -$804 |
| Net Acquisitions | $0 | $0 | $0 | $4 |
| Inv. Purchases | $0 | $0 | $0 | -$50,711 |
| Inv. Sales/Matur. | $0 | $9,998 | $25,251 | $15,250 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$192 | $9,659 | $24,791 | -$36,261 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $52,731 | $29,627 | $19,968 | $85,311 |
| Stock Repurch. | $0 | -$330 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$43 | -$108 | $567 | $296 |
| Financing Cash Flow | $52,688 | $29,054 | $20,535 | $85,607 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $4,360 | -$11,916 | $6,452 | $6,131 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $11,880 | $23,796 | $17,344 | $11,213 |
| End Cash | $16,240 | $11,880 | $23,796 | $17,344 |
| Free Cash Flow | -$48,328 | -$50,968 | -$39,334 | -$44,019 |